Skip to main navigation Skip to search Skip to main content

Regulatory Effects of Lycium barbarum Extract and Isolated Scopoletin on Atopic Dermatitis-Like Skin Inflammation

  • Seon Gyeong Bak
  • , Hyung Jin Lim
  • , Yeong Seon Won
  • , Soyoung Lee
  • , Sun Hee Cheong
  • , Seong Jin Lee
  • , Eun Young Bae
  • , Seung Woong Lee
  • , Seung Jae Lee
  • , Mun Chual Rho
  • Korea Research Institute of Bioscience and Biotechnology
  • Chonnam National University
  • Cha Meditech Co. Ltd.
  • Elohim Co. Ltd

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Lycium barbarum and scopoletin are widely used in oriental Eastern medicine and are often consumed as teas. In this study, proinflammatory cytokines expressed in human keratinocytes (HaCaT) were induced by skin diseases caused by 2,4-dinitrochlorobenzene (DNCB) and tumor necrosis factor alpha (TNF-α)/interferon gamma (IFN-γ). The inhibitory activity of L. barbarum EtOH extract (LBE) and scopoletin on proinflammatory cytokines and chemokines was investigated. In the DNCB-induced animal model, oral administration of LBE inhibited skin lesions and proinflammatory cytokines and chemokines and showed inhibitory effects in vitro. Additionally, as a result of examining the efficacy of scopoletin isolated from L. barbarum, scopoletin in HaCaT cells showed inhibitory effects on proinflammatory cytokines and chemokines. It shows promise in the treatment of chronic skin diseases.

Original languageEnglish
Article number2475699
JournalBioMed Research International
Volume2022
DOIs
StatePublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Regulatory Effects of Lycium barbarum Extract and Isolated Scopoletin on Atopic Dermatitis-Like Skin Inflammation'. Together they form a unique fingerprint.

Cite this